Anika Therapeutics Inc. (ANIK)
NASDAQ: ANIK
· Real-Time Price · USD
14.52
-0.01 (-0.07%)
At close: May 01, 2025, 3:59 PM
14.46
-0.38%
After-hours: May 01, 2025, 04:20 PM EDT
Anika Therapeutics Revenue
Anika Therapeutics reported an annual revenue of $119.91M, reflecting a -28.05% growth. For the quarter ending December 31, 2024, Anika Therapeutics generated -$1.29M in revenue.
Revenue (ttm)
$119.91M
Revenue Growth
-28.05%
Price / Sales Ratio
2.02
Revenue / Employee
$416.34K
Employees
288
Market Cap
205.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 119.91M | -28.05% |
| Dec 31, 2023 | 166.66M | +6.67% |
| Dec 31, 2022 | 156.24M | +5.71% |
| Dec 31, 2021 | 147.79M | +13.29% |
| Dec 31, 2020 | 130.46M | n/a |